Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
Inorganic ion
Predicted metabolite or user's structure
Generic receptor
Receptors with enzyme activity

Normal process
Pathological process
Covalent modifications
Transcription regulation
MicroRNA binding
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Development FGF-family signaling

Log In to Post A Comment

Development FGF-family signaling

FGF-family signaling

Fibroblast growth factors ( FGFs ) have been implicated in diverse cellularprocesses including apoptosis, cell survival, chemotaxis, cell adhesion, migration,differentiation, and proliferation [1].

FGFs comprise a family of 22 genes encoding structurally related proteins.FGFs mediate their cellular responses by binding to and activating a family offour receptor tyrosine kinases (RTKs) with designated high affinity for Fibroblast growthfactor receptors FGFR1 - FGFR4.

FGFR s have different ligand-binding characteristics. FGFR1 bindsFGF1, FGF2, FGF3, FGF4 and FGF10. FGFR2 bindsFGF1, FGF2, FGF3, FGF4, FGF7 and FGF10.FGFR3 binds FGF1, FGF2, FGF8 and FGF9. FGFR4 bindsFGF1, FGF2, FGF6, FGF16 and FGF19.

FGF activity and specificity are further regulated by heparan sulfateproteoglycans (such as Heparan sulfate proteoglycan 2 ( Perlecan )).Heparin associates with FGFs and FGFRs to form trimeric complexes[2].

The most common pathway employed by FGFs is the Mitogen-activated proteinkinase (MAPK) pathway. It involves lipid-anchored docking protein fibroblast growthfactor receptor substrate 2 ( FRS2 ) that constitutively binds with FGFR1,FGFR2 and FGFR3, but not FGFR4. FRS2 tyrosinephosphorylation sites are recognized and bound by the adapter protein Growth factorreceptor-bound protein 2 ( GRB2 ) and the protein tyrosine phosphatase (PTP)Tyrosine phosphatase non-receptor type 11 ( SHP-2 ) , as an adapterprotein. FGFR1, FGFR3, FGFR4 are able to phosphorylate SHC transforming protein (Shc ) directly. Shc and GRB2 form a complex with the guaninenucleotide exchange factor Son of sevenless ( SOS ) via its SH3 domain.Translocation of this complex to the plasma membrane by binding to phosphorylatedFRS2 allows SOS to activate Harvey rat sarcoma viral oncogene homolog (H-Ras ) by GTP exchange due to its close proximity to membrane-bound H-Ras. Once in the active GTP-bound state, H-Ras interacts with several effectorproteins leading to the activation of the Mitogen-activated protein kinase ( ERK )signaling cascade. This cascade leads to cell proliferation.

Assembly of FRS2/ GRB2/ GRB2-associated binding protein 1 (GAB1 ) complex is induced by FGF stimulation that results in activation ofPhosphatidylinositol-3 kinase ( PI3K ) and downstream effector proteins, such asV-akt murine thymoma viral oncogene homolog 1 ( AKT(PKB) ), whose cellularlocalization and activity are regulated by products of PI3K, Phosphatidylinositol3,4,5-triphosphate ( PtdIns(3,4,5)P3 )[3].

FGF plays a critical role in membrane phospholipid hydrolysis in the cell. Uponbinding to FGFR1, FGFR3, FGFR4, FGFs stimulates cytosolicform of Phospholipase C-gamma1 ( PLC-gamma 1 ). PLC-gamma activation byFGF leads to Phosphatidylinositol 4,5-biphosphate ( PtdIns(4,5)P2 )hydrolysis and generation of two second messengers, Diacylglycerol ( DAG ) andIP3. IP3 activates IP3 receptor ( IP3 receptor ) and accumulationof Ca 2+ in the cytoplasm. DAG activates Protein kinase C delta( PKC-delta ) [4].